Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-28
DOI
10.1038/s41467-021-23561-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondrial DNA editing in mice with DddA-TALE fusion deaminases
- (2021) Hyunji Lee et al. Nature Communications
- Engineering adeno-associated virus vectors for gene therapy
- (2020) Chengwen Li et al. NATURE REVIEWS GENETICS
- A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing
- (2020) Beverly Y. Mok et al. NATURE
- Mitochondrial DNA Base Editing: Good Editing Things Still Come in Small Packages
- (2020) Sandra R. Bacman et al. MOLECULAR CELL
- Mitochondrial Diseases: A Diagnostic Revolution
- (2020) Katherine R. Schon et al. TRENDS IN GENETICS
- Neurotropic Properties of AAV-PHP.B Are Shared among Diverse Inbred Strains of Mice
- (2019) Yasunori Matsuzaki et al. MOLECULAR THERAPY
- The Influence of Murine Genetic Background in Adeno-Associated Virus Transduction of the Mouse Brain
- (2019) Ting He et al. Human Gene Therapy Clinical Development
- mitoTev‐TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels
- (2018) Claudia V Pereira et al. EMBO Molecular Medicine
- Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol
- (2018) Lili Wang et al. NATURE BIOTECHNOLOGY
- Mitochondrial Genome Engineering: The Revolution May Not Be CRISPR-Ized
- (2018) Payam A. Gammage et al. TRENDS IN GENETICS
- Linear mitochondrial DNA is rapidly degraded by components of the replication machinery
- (2018) Viktoriya Peeva et al. Nature Communications
- MitoTALEN reduces mutant mtDNA load and restores tRNAAla levels in a mouse model of heteroplasmic mtDNA mutation
- (2018) Sandra R. Bacman et al. NATURE MEDICINE
- Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo
- (2018) Payam A. Gammage et al. NATURE MEDICINE
- Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina
- (2017) D G Hickey et al. GENE THERAPY
- Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS
- (2017) Nicholas M. Kanaan et al. Molecular Therapy-Nucleic Acids
- Men and mice: Relating their ages
- (2016) Sulagna Dutta et al. LIFE SCIENCES
- Timing of Gene Therapy Interventions: The Earlier, the Better
- (2016) Steven J Gray MOLECULAR THERAPY
- Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs
- (2016) Payam A. Gammage et al. NUCLEIC ACIDS RESEARCH
- A Phenotype-Driven Approach to Generate Mouse Models with Pathogenic mtDNA Mutations Causing Mitochondrial Disease
- (2016) Johanna H.K. Kauppila et al. Cell Reports
- Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
- (2016) Demet Candas et al. Jove-Journal of Visualized Experiments
- Mitochondrial diseases
- (2016) Gráinne S. Gorman et al. Nature Reviews Disease Primers
- Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease
- (2015) Gráinne S. Gorman et al. ANNALS OF NEUROLOGY
- Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids
- (2015) Lili Wang et al. MOLECULAR THERAPY
- MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases
- (2015) Masami Hashimoto et al. MOLECULAR THERAPY
- Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations
- (2014) P. A. Gammage et al. EMBO Molecular Medicine
- GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
- (2014) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells
- (2013) A. T. Martino et al. BLOOD
- Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery
- (2013) A B Katwal et al. GENE THERAPY
- Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs
- (2013) Sandra R Bacman et al. NATURE MEDICINE
- Targeted DNA excision in Arabidopsis by a re-engineered homing endonuclease
- (2012) Mauricio S Antunes et al. BMC BIOTECHNOLOGY
- Manipulation of mtDNA heteroplasmy in all striated muscles of newborn mice by AAV9-mediated delivery of a mitochondria-targeted restriction endonuclease
- (2011) S R Bacman et al. GENE THERAPY
- Retro-orbital injections in mice
- (2011) Tal Yardeni et al. LAB ANIMAL
- Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease
- (2010) S R Bacman et al. GENE THERAPY
- The I-CreI meganuclease and its engineered derivatives: applications from cell modification to gene therapy
- (2010) S. Arnould et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Mitochondrial DNA mutations and human disease
- (2009) Helen A.L. Tuppen et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Adeno-Associated Virus (AAV) Serotype 9 Provides Global Cardiac Gene Transfer Superior to AAV1, AAV6, AAV7, and AAV8 in the Mouse and Rat
- (2008) Lawrence T. Bish et al. HUMAN GENE THERAPY
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
- (2008) Carmela Zincarelli et al. MOLECULAR THERAPY
- Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA
- (2008) Michal Minczuk et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now